Showing results (221-230 of 236) with videos related to

Sort By:
Pageof 24
Journal of Neural Transmission (Vienna, Austria : 1996)|May 31, 2021
Autoantibody-associated psychiatric syndromes in children: link to adult psychiatryNiels Hansen, Daniel Luedecke, Berend Malchow, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 11, 2025
C5 complement inhibition versus FcRn modulation in generalised myasthenia gravisNiklas Huntemann, Lea Gerischer, Meret Herdick, et al.
Nature Communications|June 8, 2023
Astrocyte-oligodendrocyte interaction regulates central nervous system regenerationIrene Molina-Gonzalez, Rebecca K Holloway, Zoeb Jiwaji, et al.
Neurological Research and Practice|May 13, 2026
Multicentric prognostic observational study on biomarker profile in immunotherapy-naïve patients with highly active generalized myasthenia gravis (PROGNO-MG): a study protocolFelix Kohle, Franz Felix Konen, Ulrike Grittner, et al.
Transplantation and Cellular Therapy|June 10, 2026
Polyomavirus-Specific T Cells in Progressive Multifocal Leukoencephalopathy: A Multicenter Retrospective AnalysisAlexandre Chevalier, Baptiste Bonneau, Lea Grote-Levi, et al.
Autoimmunity Reviews|February 13, 2025
Oligoclonal bands and kappa free light chains: Competing parameters or complementary biomarkers?Franz F Konen, Ulrich Wurster, Philipp Schwenkenbecher, et al.
Acta Neuropathologica|June 18, 2024
Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravisChristina B Schroeter, Christopher Nelke, Frauke Stascheit, et al.
Multiple Sclerosis and Related Disorders|November 24, 2023
Patient-reported outcome parameters and disability worsening in progressive multiple sclerosisAhmed Abdelhak, Kai Antweiler, Markus C Kowarik, et al.
Frontiers in Neurology|February 6, 2026
The Berlin-Hannover ICANS severity assessment-a novel bedside test to evaluate CAR T-cell-associated neurotoxicityLotta Völker, Leonie Müller-Jensen, Sophia Carl, et al.
Journal of Neurology|February 27, 2026
Early versus late add-on therapy in generalized myasthenia gravis: a multicenter real-world cohort studyMenekse Oeztuerk, Niklas Huntemann, Lea Gerischer, et al.
Pageof 24